患者年龄与高级别前列腺癌在MRI可疑病灶靶向活检中的交互作用
基于2012年6月至2022年12月前瞻性纳入的2677例无前列腺癌病史且至少有一个PI-RADS≥3病灶的男性,评估年龄与PI-RADS评分对MRI靶向活检检出的前列腺癌分级的影响。靶向活检检出临床显著前列腺癌1264例(47%)、高危前列腺癌321例(12%),高龄组中两者患病率均显著更高。多变量分析显示年龄与临床显著前列腺癌显著相关但与高危前列腺癌无关,PI-RADS评分及年龄与PI-RADS评分的交互作用与高危前列腺癌显著相关但与临床显著前列腺癌无关。
要点
- 2677例男性中靶向活检检出临床显著前列腺癌47%、高危前列腺癌12%。
- 高龄组临床显著前列腺癌和高危前列腺癌患病率均显著更高。
- 年龄与临床显著前列腺癌显著相关,但与高危前列腺癌无关。
核心结论
- 在本队列中,高龄男性MRI-超声融合靶向活检的高危前列腺癌检出率较高,且与MRI表现显著相关,支持活检前MRI用于定位甚至在高龄男性中也可能导致癌症死亡的病变。
研究设计与样本
- 前瞻性纳入的经机构审查委员会批准的MRI靶向活检与系统活检对比研究,纳入时间为2012年6月至2022年12月。
- 纳入至少有一个活检前MRI PI-RADS≥3病灶且无前列腺癌病史的男性,共2677例。
- 采用有序和二元逻辑回归分析。
主要发现
- 最高PI-RADS评分为3分者1220例(46%),4分者950例(36%),5分者507例(19%)。
- 患者年龄中位数(IQR)为66.7(60.8-71.8)岁,PSA中位数(IQR)为6.1(4.6-9.0)ng/mL,前列腺体积中位数(IQR)为48(34-68)mL,PSA密度中位数(IQR)为0.13(0.08-0.20)ng/mL/mL。
- 靶向活检检出临床显著前列腺癌1264例(47%),高危前列腺癌321例(12%)。
- 高龄组中临床显著前列腺癌和高危前列腺癌的患病率均显著更高。
- 多变量分析中,患者年龄与临床显著前列腺癌显著相关但与高危前列腺癌无关;PI-RADS评分及年龄与PI-RADS评分的交互作用与高危前列腺癌显著相关但与临床显著前列腺癌无关。
临床怎么用
- 作者认为,高龄男性MRI-超声融合靶向活检的高危前列腺癌检出率较高且与MRI表现显著相关,支持活检前MRI用于定位甚至在高龄男性中也可能导致癌症死亡的病变。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the interaction of patient age and Prostate Imaging-Reporting and Data System (PI-RADS) score in determining the grade of prostate cancer (PCa) identified on magnetic resonance imaging (MRI)-targeted biopsy in older men. PATIENTS AND METHODS: From a prospectively accrued Institutional Review Board-approved comparative study of MRI-targeted and systematic biopsy between June 2012 and December 2022, men with at least one PI-RADS ≥3 lesion on pre-biopsy MRI and no prior history of PCa were selected. Ordinal and binomial logistic regression analyses were performed. RESULTS: A total of 2677 men met study criteria. The highest PI-RADS score was 3 in 1220 men (46%), 4 in 950 men (36%), and 5 in 507 men (19%). The median (interquartile range [IQR]) patient age was 66.7 (60.8-71.8) years, median (IQR) prostate-specific antigen (PSA) level was 6.1 (4.6-9.0) ng/mL, median (IQR) prostate volume was 48 (34-68) mL, and median (IQR) PSA density was 0.13 (0.08-0.20) ng/mL/mL. Clinically significant (cs)PCa and high-risk PCa were identified on targeted biopsy in 1264 (47%) and 321 (12%) men, respectively. Prevalence of csPCa and high-risk PCa were significantly higher in the older age groups. On multivariable analyses, patient age was significantly associated with csPCa but not high-risk PCa; PI-RADS score and the interaction of age and PI-RADS score were significantly associated with high-risk PCa but not csPCa. CONCLUSION: In our cohort, the substantial rate of high-risk PCa on MRI-ultrasound fusion targeted biopsies in older men, and its significant association with MRI findings, supports the value of pre-biopsy MRI to localise disease that could cause cancer mortality even in older men.
引用
- Pak JS, Huang R, Huang WC, et al. Interaction of patient age and high-grade prostate cancer on targeted biopsies of MRI suspicious lesions. BJU Int. 2024. PMID: 38533536. doi:10.1111/bju.16341
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。